Stockscreener 앱 받기
38.96
10.58%
-4.61
시간 외 거래:
38.20
-0.76
-1.95%
전일 마감가:
$43.57
열려 있는:
$40.76
하루 거래량:
710.91K
Relative Volume:
2.37
시가총액:
$1.74B
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-12.21%
1개월 성능:
+1.96%
6개월 성능:
+184.59%
1년 성능:
+0.00%
1일 변동 폭
$35.42
$41.11
1주일 범위
$35.42
$44.80
52주 변동 폭
$7.255
$45.00
Sionna Therapeutics Inc Stock (SION) Company Profile
명칭
Sionna Therapeutics Inc
전화
617-819-2020
주소
21 HICKORY DRIVE, SUITE 500, WALTHAM
SION을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SION
Sionna Therapeutics Inc
|
38.96 | 1.94B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.60 | 110.02B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
750.11 | 82.00B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.56 | 59.61B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
894.90 | 56.15B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
211.41 | 44.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Sionna Therapeutics Inc Stock (SION) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-19 | 개시 | BTIG Research | Buy |
| 2025-09-03 | 개시 | RBC Capital Mkts | Sector Perform |
| 2025-09-03 | 개시 | Raymond James | Strong Buy |
| 2025-03-04 | 개시 | Guggenheim | Buy |
| 2025-03-04 | 개시 | Stifel | Buy |
| 2025-03-04 | 개시 | TD Cowen | Buy |
모두보기
Sionna Therapeutics Inc 주식(SION)의 최신 뉴스
Sionna Therapeutics Shares Lower After RBC Downgrade - MarketScreener
Sionna Therapeutics stock tumbles after RBC downgrade By Investing.com - Investing.com Canada
SION Downgraded by RBC Capital: Today's Analyst Rating | SION Stock News - GuruFocus
RBC Downgrades Sionna Therapeutics to Underperform From Sector Perform, Keeps $24 Price Target, Speculative Risk - MarketScreener
What drives Sionna Therapeutics Inc stock priceEarnings Forecast Updates & Rapid Capital Trading - earlytimes.in
Sionna Therapeutics Insider Sold Shares Worth $4,814,205, According to a Recent SEC Filing - MarketScreener
OrbiMed Advisors sells Sionna Therapeutics (SION) stock worth $4.8m By Investing.com - Investing.com Nigeria
OrbiMed Advisors sells Sionna Therapeutics (SION) stock worth $4.8m - Investing.com India
Shareholder OrbiMed Advisors LLC Sells 108,073 ($4.8M) Of Sionna Therapeutics Inc [SION] - TradingView
Major Stock Sell-Off by Sionna Therapeutics Directors! - TipRanks
Major Stock Sale Alert: Sionna Therapeutics Shares on the Move! - TipRanks
Shareholder Orbimed Private Investments Viii Lp Files To Sell 1,047,770 Of Sionna Therapeutics Inc [SION] - TradingView
Owner RA Capital Management LP Sells 30,316 ($1.2M) Of Sionna Therapeutics Inc [SION] - TradingView
RA Capital funds report SION insider stock sales in Form 4 filing - Stock Titan
SION Crosses Above Average Analyst Target - Nasdaq
Sionna Therapeutics to Participate in Upcoming December Investor Conferences - Yahoo Finance
Owner Blackwell Partners LLC-Series A Files To Sell 7,609 Of Sionna Therapeutics Inc [SION] - TradingView
Is Sionna Therapeutics Inc. stock a smart buy before Fed meetingGap Down & High Yield Equity Trading Tips - newser.com
Will Sionna Therapeutics Inc. stock reach Wall Street targetsMarket Risk Report & Reliable Intraday Trade Alerts - newser.com
Sionna Therapeutics (NASDAQ:SION) Upgraded at BTIG Research - Defense World
Ra Capital sold Sionna Therapeutics (SION) shares worth $5.5m By Investing.com - Investing.com Nigeria
Ra Capital sold Sionna Therapeutics (SION) shares worth $5.5m - Investing.com
[Form 4] Sionna Therapeutics, Inc. Insider Trading Activity - Stock Titan
Owner RA Capital Management LP Sells 136,351 ($5.5M) Of Sionna Therapeutics Inc [SION] - TradingView
Sionna Therapeutics(SION.US) 10% Shareholder Sells US$5.5 Million in Common Stock - 富途牛牛
Is Sionna Therapeutics Inc. stock a safe buy before earningsTrade Risk Report & Risk Controlled Daily Plans - newser.com
Owner RA Capital Healthcare Fund LP Files To Sell 2,278 Of Sionna Therapeutics Inc [SION] - TradingView
How Sionna Therapeutics Inc. stock performs in rising dollar environmentMarket Growth Summary & Short-Term Trading Opportunity Alerts - newser.com
What Fibonacci levels say about Sionna Therapeutics Inc. reboundJuly 2025 Intraday Action & Free AI Powered Buy and Sell Recommendations - newser.com
What Wall Street predicts for Sionna Therapeutics Inc. stock price2025 Geopolitical Influence & Capital Protection Trading Alerts - newser.com
Will Sionna Therapeutics Inc. stock go up soonJuly 2025 Trade Ideas & Safe Entry Point Alerts - newser.com
BTIG Research Initiates Coverage on Sionna Therapeutics With Buy Rating, $50 Price Target - MarketScreener
BTIG Initiates Coverage of Sionna Therapeutics (SION) with Buy Recommendation - Nasdaq
How analysts rate Sionna Therapeutics Inc. stock todayQuarterly Investment Review & Free Expert Approved Momentum Trade Ideas - newser.com
BTIG Assigns Buy Rating to Sionna Therapeutics, Citing Innovative Cystic Fibrosis Therapies and Strong Market Potential - TipRanks
Is Sionna Therapeutics Inc. stock a safe haven assetJuly 2025 Drop Watch & Safe Entry Point Identification - newser.com
All You Need to Know About Sionna Therapeutics, Inc. (SION) Rating Upgrade to Buy - MSN
Sionna Therapeutics Inc (SION) 재무 분석
Sionna Therapeutics Inc (SION)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
Sionna Therapeutics Inc 주식 (SION) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | Director |
Nov 25 '25 |
Sale |
44.60 |
11,890 |
530,294 |
3,598,486 |
| ORBIMED ADVISORS LLC | Director |
Nov 26 '25 |
Sale |
44.49 |
1,600 |
71,184 |
3,596,886 |
| Thompson Peter A. | Director |
Nov 24 '25 |
Sale |
44.54 |
94,583 |
4,212,727 |
3,610,376 |
| Thompson Peter A. | Director |
Nov 25 '25 |
Sale |
44.60 |
11,890 |
530,294 |
3,598,486 |
| Thompson Peter A. | Director |
Nov 26 '25 |
Sale |
44.49 |
1,600 |
71,184 |
3,596,886 |
0.30%
1.75%
자본화:
|
볼륨(24시간):